Chair: Welcome back to the Reconvened 67th Session. We will continue the consideration on Item 4 on strategic management, budgetary and administrative questions. At our joint meeting with the CCPCJ yesterday, we considered under Agenda Item 4 the implementation of the consolidated for the biennium 2024-2025 for the UNODC. And the drugs proposed program plan …
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Hello, good afternoon, everyone. Welcome back. Let’s begin the afternoon session. Introductory remarks: Mr. Michael Osman, Social Affairs Officer, Border Management Branch, UNODC: I’ll provide a brief overview to leave more time for our interactive discussions …
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Welcome back. Ms. Asma Fakhri, UNODC, on behalf of Mr. Justice TETTEY, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC (Moderator): Thank you all for gathering to address the growing challenges posed by synthetic opioids and the non-medical …
Canada: Esteemed Chair, Ministers, Heads of Delegation, Distinguished Delegates, and Civil Society Representatives: Canada is experiencing one of the most serious public health crises in our country’s history: an unrelenting toxic drug and overdose crisis. The impact and scope of the toxic drug crisis is devastating and more complex than ever. Tragically, we have seen …
Chair: Good morning, everyone. Welcome to the second part of the 2023 Thematic Discussion of the Commission on Narcotic Drugs on the implementation of all international drug policy commitments following the 2019 ministerial declaration (…) Agenda is adopted. Thank you very much. Secretariat: (organizational announcements) Director of the Division of Policy Analysis and Public Affairs …
Chair: Welcome back. The challenge that we will be focusing on this afternoon responses not in conformity with the three international drug conventions, and not in conformity with applicable international human rights obligations pose a challenge to the implementation of joint commitment based on the principle of responsibility. UNODC Scientific Services Branch: I have a brief moment …